Wolverine Trading
TVRD

Wolverine Trading’s Tvardi Therapeutics TVRD Stock Holding History

Wolverine Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-308
Closed -$107K – 5513
2022
Q2 		$107K Buy
+308
New +$108K ﹤0.01% 3826
2022
Q1 		– Sell
-478
Closed -$212K – 6665
2021
Q4 		$212K Buy
+478
New +$240K ﹤0.01% 4628
2021
Q3 		– Sell
-797
Closed -$414K – 7136
2021
Q2 		$414K Buy
797
+216
+37% +$137K ﹤0.01% 3972
2021
Q1 		$430K Buy
581
+6
+1% +$4.11K ﹤0.01% 3925
2020
Q4 		$318K Sell
575
-28
-5% -$14.7K ﹤0.01% 3683
2020
Q3 		$268K Sell
603
-683
-53% -$397K ﹤0.01% 3530
2020
Q2 		$777K Buy
1,286
+89
+7% +$49.2K ﹤0.01% 2262
2020
Q1 		$572K Buy
1,197
+69
+6% +$37.5K ﹤0.01% 2508
2019
Q4 		$666K Sell
1,128
-580
-34% -$407K ﹤0.01% 2804
2019
Q3 		$1.15M Sell
1,708
-59
-3% -$49K ﹤0.01% 1855
2019
Q2 		$1.37M Sell
1,767
-822
-32% -$578K ﹤0.01% 1788
2019
Q1 		$1.83M Buy
2,589
+1,150
+80% +$688K 0.01% 1603
2018
Q4 		$658K Buy
1,439
+217
+18% +$140K ﹤0.01% 2378
2018
Q3 		$1.05M Buy
1,222
+430
+54% +$310K ﹤0.01% 2298
2018
Q2 		$353K Hold
792
– – ﹤0.01% 3554
2018
Q1 		$353K Buy
+792
New +$384K ﹤0.01% 3554

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wolverine Trading's TVRD Position: Q3 2021 in Review

Wolverine Trading sold out of Tvardi Therapeutics (TVRD) in Q3 2021, closing a stake of 496 shares — an estimated $258K sold.

Wolverine Trading first reported a position in TVRD in Q1 2018 and held it in 13 quarters. The position peaked at $1.05M in Q1 2019. 168 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

  • Wolverine Trading reported no remaining Tvardi Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 496 Tvardi Therapeutics shares in Q3 2021, an estimated $258K.
  • Wolverine Trading first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 13 quarters.
  • Wolverine Trading's Tvardi Therapeutics position peaked at $1.05M in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.